prexasertib   Click here for help

GtoPdb Ligand ID: 9549

Synonyms: LY2606368
Compound class: Synthetic organic
Comment: Prexasertib (LY2606368), an investigational small molecule checkpoint kinase 1 (CHK1) inhibitor [2] that exhibits anti-tumour activity in preclinical models of pediatric cancer.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 134.76
Molecular weight 365.16
XLogP 1.73
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCOc1cccc(c1c1[nH]nc(c1)Nc1cnc(cn1)C#N)OC
Isomeric SMILES NCCCOc1cccc(c1c1[nH]nc(c1)Nc1cnc(cn1)C#N)OC
InChI InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)
InChI Key DOTGPNHGTYJDEP-UHFFFAOYSA-N
References
1. King C, Diaz HB, McNeely S, Barnard D, Dempsey J, Blosser W, Beckmann R, Barda D, Marshall MS. (2015)
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms.
Mol Cancer Ther, 14 (9): 2004-13. [PMID:26141948]
2. Lowery CD, VanWye AB, Dowless M, Blosser W, Falcon BL, Stewart J, Stephens J, Beckmann RP, Bence Lin A, Stancato LF. (2017)
The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma.
Clin Cancer Res, 23 (15): 4354-4363. [PMID:28270495]